SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
von Stillfried, Saskia
Ibarra, Ignacio L
Chua, Robert Lorenz
Hiller, Anna Luisa
Bülow, Roman David
Leipold, Alexander M
Aschenbrenner, Anna C
Heppner, Frank L
Schultze, Joachim L
Hauser, Anja E
Luecken, Malte D
Theis, Fabian J
Sander, Leif Erik
MetadataShow full item record
AbstractCOVID-19-induced "acute respiratory distress syndrome" (ARDS) is associated with prolonged respiratory failure and high mortality, but the mechanistic basis of lung injury remains incompletely understood. Here, we analyze pulmonary immune responses and lung pathology in two cohorts of patients with COVID-19 ARDS using functional single-cell genomics, immunohistology, and electron microscopy. We describe an accumulation of CD163-expressing monocyte-derived macrophages that acquired a profibrotic transcriptional phenotype during COVID-19 ARDS. Gene set enrichment and computational data integration revealed a significant similarity between COVID-19-associated macrophages and profibrotic macrophage populations identified in idiopathic pulmonary fibrosis. COVID-19 ARDS was associated with clinical, radiographic, histopathological, and ultrastructural hallmarks of pulmonary fibrosis. Exposure of human monocytes to SARS-CoV-2, but not influenza A virus or viral RNA analogs, was sufficient to induce a similar profibrotic phenotype in vitro. In conclusion, we demonstrate that SARS-CoV-2 triggers profibrotic macrophage responses and pronounced fibroproliferative ARDS.
CitationCell. 2021 Dec 22;184(26):6243-6261.e27. doi: 10.1016/j.cell.2021.11.033. Epub 2021 Nov 27. PMID: 34914922.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.
- Authors: Lee JW, Chun W, Lee HJ, Min JH, Kim SM, Seo JY, Ahn KS, Oh SR
- Issue date: 2021 Apr 14
- Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19.
- Authors: Aloufi N, Traboulsi H, Ding J, Fonseca GJ, Nair P, Huang SK, Hussain SNA, Eidelman DH, Baglole CJ
- Issue date: 2021 Jan 1
- The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
- Authors: Kosyreva A, Dzhalilova D, Lokhonina A, Vishnyakova P, Fatkhudinov T
- Issue date: 2021
- Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
- Authors: Margaroli C, Benson P, Sharma NS, Madison MC, Robison SW, Arora N, Ton K, Liang Y, Zhang L, Patel RP, Gaggar A
- Issue date: 2021 Apr 20
- Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
- Authors: Fließer E, Birnhuber A, Marsh LM, Gschwandtner E, Klepetko W, Olschewski H, Kwapiszewska G
- Issue date: 2021 Sep